Amy Raskopf | Vice President-Investor Relations |
Saundra Pelletier | Chief Executive Officer, President and Executive Director |
Jay File | Chief Financial Officer |
David Amsellem | Piper Sandler |
Stacy Lee | Stifel |
Yale Jen | Laidlaw |
Ram Selvaraju | H.C. Wainwright |
Greetings, and welcome to the Evofem Biosciences’ First Quarter of 2022 Financial Results Call. At this time, all participants are in a listen only mode. A brief question-and-answer session will follow the formal presentation. [Operator Instructions] As a reminder this conference is being recorded. It is now my pleasure to introduce your host, Amy Raskopf, Evofem's Vice President of Investor Relations.